| Respiratory Tract Infections |
0 |
1 |
| Pediatric Respiratory Infections |
0 |
0.99 |
| Child |
0 |
0.36 |
| Diarrhea |
0 |
0.36 |
| Influenza |
0 |
0.98 |
| Respiratory Tract |
0 |
0.97 |
| HIV Infection |
0 |
0.27 |
| Proton Pump Inhibitor |
0 |
0.26 |
| Accomodation |
0 |
0.18 |
| Adverse Effects |
0 |
0.18 |
| Anti-inflammatory Agents |
0 |
0.18 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.18 |
| Chronic Disease |
0 |
0.18 |
| Complementary and Alternative Medicine |
0 |
0.18 |
| COVID-19 |
0 |
0.18 |
| Epithelium |
0 |
0.18 |
| Geriatrics |
0 |
0.18 |
| Integrative Medicine |
0 |
0.18 |
| Meta-Analysis |
0 |
0.18 |
| Mouth |
0 |
0.18 |
| Nausea |
0 |
0.18 |
| New York |
0 |
0.18 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.18 |
| Patient Safety |
0 |
0.18 |
| Travel Medicine |
0 |
0.18 |
| Viral Infection |
0 |
0.18 |